+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Thrombolytics"

Thrombolytic Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Thrombolytic Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Specific Thrombolytic Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Specific Thrombolytic Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 194 Pages
  • Global
From
From
From
Reteplase Market - Global Forecast 2026-2032 - Product Thumbnail Image

Reteplase Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
Urokinase Market - Global Forecast 2026-2032 - Product Thumbnail Image

Urokinase Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
From
Thrombosis Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Thrombosis Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
From
From
Acute Coronary Syndrome Market - Global Forecast 2026-2032 - Product Thumbnail Image

Acute Coronary Syndrome Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 182 Pages
  • Global
From
From
From
From
Cardiovascular Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cardiovascular Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 189 Pages
  • Global
From
Stroke Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Stroke Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 367 Pages
  • Global
From
Pulmonary Embolism Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Embolism Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 268 Pages
  • Global
From
Urokinase - Global Strategic Business Report 2026 - Product Thumbnail Image

Urokinase - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 279 Pages
  • Global
From
Thrombosis Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 387 Pages
  • Global
From
From
Loading Indicator

Thrombolytics are a class of cardiovascular drugs used to treat acute ischemic stroke, myocardial infarction, and pulmonary embolism. They work by breaking down the clot that is blocking the blood vessel, allowing blood to flow freely. Thrombolytics are typically administered intravenously, and can be used in combination with other treatments such as anticoagulants and antiplatelet drugs. The most commonly used thrombolytic is tissue plasminogen activator (tPA), which is a recombinant form of the naturally occurring enzyme plasminogen. The thrombolytics market is highly competitive, with a number of companies offering products for the treatment of cardiovascular diseases. Some of the major players in the market include Boehringer Ingelheim, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. Show Less Read more